Axonics Inc (NAS:AXNX)
$ 67.22 -0.11 (-0.16%) Market Cap: 3.43 Bil Enterprise Value: 3.13 Bil PE Ratio: 0 PB Ratio: 5.47 GF Score: 85/100

Axonics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 03:05PM GMT
Release Date Price: $78.12 (+1.72%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Good morning, everyone. Again, welcome to the first day of the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst here at Morgan Stanley. And it is my pleasure to have Axonics with us today. Ray Cohen, CEO; and Dan Dearen, CFO.

And before we get started, really quickly, disclosures -- for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. So with that, very happy to have both of you here.

Questions & Answers

Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Thank you for being here. And would love to just start where I think a lot of conversations these days seem to start on the macro, on the outlook for the back half of this year.

But I think across the board, we hear a lot of med tech companies, especially deferrable procedure companies talking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot